Apraclonidine Hydrochloride and Zanamivir Inhalation, oral/nebulization
Determining the interaction of Apraclonidine Hydrochloride and Zanamivir Inhalation, oral/nebulization and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: apraclonidine ophthalmic
Brand name: Iopidine
Synonyms: Apraclonidine ophthalmic, Apraclonidine
Generic Name: zanamivir
Brand name: Relenza
Synonyms: Zanamivir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Apraclonidine Hydrochloride-Zanosar
- Apraclonidine Hydrochloride-Zantac
- Apraclonidine Hydrochloride-Zantac (Ranitidine Injection)
- Apraclonidine Hydrochloride-Zantac (Ranitidine Syrup)
- Apraclonidine Hydrochloride-Zantac (Ranitidine Tablets and Capsules)
- Apraclonidine Hydrochloride-Zantac Cool Mint
- Zanamivir Inhalation, oral/nebulization-Apraclonidine ophthalmic
- Zanamivir Inhalation, oral/nebulization-Apremilast
- Zanamivir Inhalation, oral/nebulization-Aprepitant
- Zanamivir Inhalation, oral/nebulization-Aprepitant Capsules
- Zanamivir Inhalation, oral/nebulization-Aprepitant Injection
- Zanamivir Inhalation, oral/nebulization-Aprepitant Intravenous